Prices delayed by at least 15 minutes | Print
AEQUUS PHARMACEUTICALS INC (AQS)
EquityOpen
0.015 CAD
Previous close
0.01 CAD
Trade high
0.015 CAD
Volume
50,000
Year high
0.06 CAD
Year low
0.01 CAD
Dividend yield
-
Market capitalisation
1.99 mn CAD
P/E ratio
-
ISIN
CA0076361033
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment.The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.